Shares of health insurance company Alignment Healthcare (NASDAQ:ALHC) jumped 3.6% in the afternoon session after positive news from industry peer UnitedHealth lifted sentiment for the health insurance sector.

The move came as shares of several health insurers, including Elevance, also gained. This sector-wide optimism was sparked by UnitedHealth's announcement that a large percentage of its members are enrolled in high-rated Medicare plans. While the Medicare Advantage market has been a significant growth driver for insurers, the industry has recently faced headwinds from rising medical costs and tighter government reimbursements, which have pressured profits. UnitedHealth's positive update appears to have eased some of these concerns for investors, boosting confidence in the sector as a whole.

After the initial pop the shares cooled down to $16.86, up 3.9% from previous close.

Is now the time to buy Alignment Healthcare? Access our full analysis report here, it’s free.

Alignment Healthcare’s shares are extremely volatile and have had 32 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 15 days ago when the stock gained 4% on the news that KeyBanc upgraded the stock to Overweight from Sector Weight, setting a price target of $21.00.

The investment firm highlighted Alignment Healthcare's integrated Medicare Advantage-value-based care model as a key strength, stating it's "emerging as a better...mousetrap vs. traditional models." KeyBanc believes the company's platform effectively improves hospital utilization, allowing savings to be reinvested into member benefits. This strategy is expected to drive long-term market share gains and superior growth compared to competitors. The bank also anticipates significant EBITDA growth for Alignment in 2026 and 2027, citing factors like maturing patient groups and improved Medicare Advantage rates. KeyBanc noted that the company's guidance for the second half of 2025 seems conservative, suggesting potential for positive performance ahead.

Alignment Healthcare is up 45.8% since the beginning of the year, but at $16.86 per share, it is still trading 14.8% below its 52-week high of $19.78 from April 2025. Investors who bought $1,000 worth of Alignment Healthcare’s shares at the IPO in March 2021 would now be looking at an investment worth $974.00.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.